CLINICAL_TRIALS
trial_result
· 2022-07-27
Clinical Trial Update: Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma [Phase 2]
Summary
Phase 2 clinical trial evaluating selected de-escalation radiotherapy for postoperative head and neck squamous cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hubei Cancer Hospital | Conditions: Head and Neck Squamous Cell Carcinoma, Radiotherapy | Phase 2 | Status: UNKNOWN